The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...
ICON has agreed to acquire PRA Health Sciences for approximately $12 billion in cash and stock, the companies said, in a deal that continues the consolidation of contract research organizations (CROs) ...
Icon had a tough 12 months but is bouncing back in 2021 with returns to growth, new collabs and, oh, that $12 billion deal to snap up a rival company. For its fourth-quarter and full-year financials, ...
Clinical-trial operator Icon PLCICLR0.48%increase; green up pointing triangle said it would acquire rival PRA Health Sciences Inc. for $12 billion, creating a powerhouse provider of services to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback